Evidence map›Paper›PMID 29033832›Full record

ArticleFrontiers in pharmacology2017

Cyclotides Isolated from an Ipecac Root Extract Antagonize the Corticotropin Releasing Factor Type 1 Receptor.

Mohsen Fahradpour, Peter Keov, Carlotta Tognola, Estela Perez-Santamarina, Peter J McCormick, Alireza Ghassempour, Christian W Gruber

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Advances in Cyclic Peptides Targeting G Protein-Coupled Receptors.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Review
  3. Peptide hormones in plants.Molecular horticulture · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Pharmaceutics · 2023
    Article
  10. Article
  11. Article
  12. Frontiers in pharmacology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Cyclotides from BrazilianJournal of natural products · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Mohsen FahradpourCenter for Physiology and Pharmacology, Medical University of ViennaVienna, Austria.
Peter KeovFaculty of Medicine, School of Biomedical Sciences, The University of Queensland, BrisbaneQLD, Australia.
Carlotta TognolaCenter for Physiology and Pharmacology, Medical University of ViennaVienna, Austria.
Estela Perez-SantamarinaCenter for Physiology and Pharmacology, Medical University of ViennaVienna, Austria.
Peter J McCormickSchool of Veterinary Medicine, University of SurreyGuildford, United Kingdom.
Alireza GhassempourMedicinal Plants and Drugs Research Institute, Shahid Beheshti UniversityTehran, Iran.
Christian W GruberCenter for Physiology and Pharmacology, Medical University of ViennaVienna, Austria.
Medical University of Vienna · ATShahid Beheshti University · IRUniversity of Queensland · AUUniversity of Surrey · GB

Funding

Austrian Science Fund FWF I 3243
6 · The paper itself

Abstract

Cyclotides are plant derived, cystine-knot stabilized peptides characterized by their natural abundance, sequence variability and structural plasticity. They are abundantly expressed in Rubiaceae, Psychotrieae in particular. Previously the cyclotide kalata B7 was identified to modulate the human oxytocin and vasopressin G protein-coupled receptors (GPCRs), providing molecular validation of the plants' uterotonic properties and further establishing cyclotides as valuable source for GPCR ligand design. In this study we screened a cyclotide extract derived from the root powder of the South American medicinal plant ipecac (

Indexed as

circular peptidecorticotropin-releasing factorGPCRipecacpharmacognosyplant peptides

Identifiers

PMID29033832
PMCPMC5627009
OpenAlexW2747787231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.